Clinical Trial

Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
significant benefits by providing data to improve infection control, guide early detection, and reduce CRE transmission in ICUs.
Trial Details
NCT Number NCT07255443
Lead Sponsor Israa Ahmed abdelhalim
Conditions Rate of Carbapenemase Intestinal Carrier Inside ICU
Enrollment 120 participants
Start Date 2026-02-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-06-05 (estimated)
Updated on ClinicalTrials.gov 2025-12-01